Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2008-04-15 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MEAUX (77100), Seine-et-Marne
PHARMACIE DE LA PIERRE COLLINET : revenue, balance sheet and financial ratios
PHARMACIE DE LA PIERRE COLLINET is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MEAUX (77100),
this company of category PME
shows in 2019 a revenue of 1.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA PIERRE COLLINET (SIREN 503599375)
Indicator
2021
2020
2019
2018
2017
Revenue
N/C
N/C
1 102 725 €
997 377 €
967 491 €
Net income
82 216 €
16 673 €
31 112 €
21 028 €
-50 264 €
EBITDA
N/C
N/C
33 965 €
29 323 €
14 665 €
Net margin
N/C
N/C
2.8%
2.1%
-5.2%
Revenue and income statement
In 2021, PHARMACIE DE LA PIERRE COLLINET generates positive net income of 82 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
82 216 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 78%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 8%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
77.604%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
7.76%
Solvency indicators evolution PHARMACIE DE LA PIERRE COLLINET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
Debt ratio
-318.762
-375.895
-610.215
-946.113
77.604
Financial autonomy
-15.248
-11.42
-6.152
-3.816
7.76
Repayment capacity
-15.228
11.259
7.299
None
None
Cash flow / Revenue
-1.863%
2.262%
2.943%
None%
None%
Sector positioning
Debt ratio
77.62021
2019
2020
2021
Q1: 29.03
Med: 85.54
Q3: 208.44
Good+22 pts over 3 years
In 2021, the debt ratio of PHARMACIE DE LA PIERRE CO... (77.60) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
7.76%2021
2019
2020
2021
Q1: 25.88%
Med: 44.4%
Q3: 64.18%
Watch
In 2021, the financial autonomy of PHARMACIE DE LA PIERRE CO... (7.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
7.3 years2019
2019
Q1: 1.73 years
Med: 5.0 years
Q3: 9.49 years
Average
In 2019, the repayment capacity of PHARMACIE DE LA PIERRE CO... (7.30) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2021)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2021)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2021)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2021)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA PIERRE COLLINET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
Operating WCR
-101 993 €
10 064 €
40 283 €
0 €
0 €
Inventory turnover (days)
0
30
39
0
0
Customer payment term (days)
0
10
8
0
0
Supplier payment term (days)
142
142
130
0
0
Positioning of PHARMACIE DE LA PIERRE COLLINET in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2021,
the value of PHARMACIE DE LA PIERRE COLLINET is estimated at
943 051 €
(range 606 386€ - 1 456 718€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2021
220 transactions
606k€943k€1456k€
943 051 €Range: 606 386€ - 1 456 718€
NAF 5 année 2021
Valuation method used
Net Income Multiple
82 216 €
×
11.5x
=943 052 €
Range: 606 387€ - 1 456 719€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA PIERRE COLLINET with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA PIERRE COLLINET
What is the revenue of PHARMACIE DE LA PIERRE COLLINET ?
The revenue of PHARMACIE DE LA PIERRE COLLINET in 2019 is 1.1 M€.
Is PHARMACIE DE LA PIERRE COLLINET profitable?
Yes, PHARMACIE DE LA PIERRE COLLINET generated a net profit of 82 k€ in 2021.
Where is the headquarters of PHARMACIE DE LA PIERRE COLLINET ?
The headquarters of PHARMACIE DE LA PIERRE COLLINET is located in MEAUX (77100), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE DE LA PIERRE COLLINET ?
The tax return of PHARMACIE DE LA PIERRE COLLINET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA PIERRE COLLINET operate?
PHARMACIE DE LA PIERRE COLLINET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart